HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

Published online before print October 23, 2003

This Article Full Text (Reprint (PDF)) All Versions of this Article: jlb.0603264v1 75/2/253    most recent Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Catania, A. Articles by Lipton, J. M. Search for Related Content PubMed PubMed Citation Articles by Catania, A. Articles by Lipton, J. M.

© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0603264

Received for publication June 11, 2003.
Revised September 30, 2003.
Accepted for publication October 4, 2003.

Article

Autocrine inhibitory influences of -melanocyte-stimulating hormone in malignant pleural mesothelioma

Anna Catania ^*@, Gualtiero Colombo ^*, Andrea Carlin ^*, Letizia Garofalo ^*, Stefano Gatti , Roberto Buffa , Nadia Carboni ^*, Lorenzo Rosso , Luigi Santambrogio , Luigi Cantalamessa ^*, and James M. Lipton

Departments of *Internal Medicine and Surgery, Ospedale Maggiore di Milano IRCCS, Italy; Institute of Pathology, University of Milano Bicocca, Monza, Italy; and Zengen, Inc., Woodlands Hills, California

^@ To whom correspondence should be addressed. E-mail: anna.catania{at}unimi.it.

	Abstract

Malignant pleural mesothelioma is a highly aggressive tumor arising from the mesothelial cells that line the pleural cavities. This tumor is resistant to most conventional anticancer treatments and appears to be very sensitive to growth-promoting influences of cytokines and growth factors. Identification of natural inhibitory pathways that control growth should aid discovery of novel therapeutic approaches. We hypothesized that -melanocyte-stimulating hormone (-MSH), which is produced by many cell types and antagonizes cytokines and growth factors, could be an endogenous, inhibitory molecule in mesothelioma. Twelve mesothelioma cell lines were established from pleural effusions of patients with malignant mesothelioma. Mesothelioma cells were found to express mRNA for proopiomelanocortin and its processing enzymes; release -MSH peptide into supernatants; and express melanocortin 1 receptor (MC1R), the high-affinity receptor for -MSH. Immunoneutralization of MC1R in the cell lines enhanced expression of interleukin-8 (IL-8), IL-6, and transforming growth factor-. These molecules promote mesothelioma proliferation and are considered therapeutic targets in this tumor. Coincubation of mesothelioma cells with synthetic -MSH significantly reduced cell proliferation. The present research shows an autocrine-inhibitory circuit based on -MSH and its receptor MC1R. Activation of MC1R by selective peptides or peptidomimetics might provide a novel strategy to reduce mesothelioma cell proliferation by taking advantage of this endogenous, inhibitory circuit.

Key Words: melanocortin receptors (MCR) • proopiomelanocortin (POMC) • malignant mesothelioma • growth factors

This article has been cited by other articles:

				G.-S. Liu, L.-F. Liu, C.-J. Lin, J.-C. Tseng, M.-J. Chuang, H.-C. Lam, J.-K. Lee, L.-C. Yang, J. H. Y. Chan, S.-L. Howng, et al. Gene Transfer of Pro-opiomelanocortin Prohormone Suppressed the Growth and Metastasis of Melanoma: Involvement of {alpha}-Melanocyte-Stimulating Hormone-Mediated Inhibition of the Nuclear Factor {kappa}B/Cyclooxygenase-2 Pathway Mol. Pharmacol., February 1, 2006; 69(2): 440 - 451. [Abstract] [Full Text] [PDF]

				Z. Zhou, A. Flesken-Nikitin, C. G. Levine, E. N. Shmidt, J. P. Eng, E. Yu. Nikitina, D. M. Spencer, and A. Yu. Nikitin Suppression of Melanotroph Carcinogenesis Leads to Accelerated Progression of Pituitary Anterior Lobe Tumors and Medullary Thyroid Carcinomas in Rb+/- Mice Cancer Res., February 1, 2005; 65(3): 787 - 796. [Abstract] [Full Text] [PDF]